(FG) F&G Annuities & Life - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30190A1043

FG: Annuities, Insurance, Life Insurance, Fixed Annuities

F&G Annuities & Life Inc. (NYSE:FG) is a prominent provider of fixed annuities and life insurance products in the United States. Established in 1959 and headquartered in Des Moines, Iowa, the company operates as a subsidiary of Fidelity National Financial, Inc., leveraging the stability and resources of its parent organization. F&Gs product portfolio is designed to meet diverse customer needs, offering fixed indexed annuities, multi-year guarantee annuities, and pension risk transfer solutions. Additionally, they provide indexed universal life insurance and institutional funding agreements, catering to both retail and institutional clients.

The companys financial standing is notable, with a market capitalization of approximately $5.85 billion. While the current P/E ratio is 0.00, the forward P/E is 4.86, indicating expected earnings growth. The price-to-book ratio of 1.35 suggests that investors value the companys assets appropriately. With a price-to-sales ratio of 1.00, F&G demonstrates a balanced approach to revenue generation and profitability.

F&Gs strategic position in the market is strengthened by its focus on predictable income products, which are particularly appealing in volatile economic conditions. The inclusion of indexed products allows for controlled market exposure, enhancing appeal to risk-conscious investors. Their expertise in pension risk transfers addresses a critical need for corporations seeking to manage liabilities, positioning F&G as a key player in this growing sector.

As a subsidiary of Fidelity National Financial, F&G benefits from a robust financial framework and extensive industry knowledge, enhancing its competitive edge. This affiliation not only provides operational stability but also access to a broader network and resources, enabling F&G to maintain its position as a reliable and innovative insurer in the U.S. market.

Additional Sources for FG Stock

FG Stock Overview

Market Cap in USD 4,690m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 2022-12-01

FG Stock Ratings

Growth Rating 48.5
Fundamental -
Dividend Rating 52.8
Rel. Strength -22.5
Analysts 3/5
Fair Price Momentum 33.55 USD
Fair Price DCF 977.17 USD

FG Dividends

Dividend Yield 12m 2.25%
Yield on Cost 5y 5.44%
Annual Growth 5y 2.44%
Payout Consistency 100.0%

FG Growth Ratios

Growth Correlation 3m -90%
Growth Correlation 12m 13.1%
Growth Correlation 5y 77.5%
CAGR 5y 38.86%
CAGR/Max DD 5y 0.94
Sharpe Ratio 12m 0.43
Alpha -19.37
Beta 1.166
Volatility 45.42%
Current Volume 137.7k
Average Volume 20d 428.5k
What is the price of FG stocks?
As of April 26, 2025, the stock is trading at USD 34.99 with a total of 137,733 shares traded.
Over the past week, the price has changed by +4.92%, over one month by -0.31%, over three months by -21.23% and over the past year by -7.53%.
Is F&G Annuities & Life a good stock to buy?
Partly, yes. Based on ValueRay Analyses, F&G Annuities & Life (NYSE:FG) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.47 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FG as of April 2025 is 33.55. This means that FG is currently overvalued and has a potential downside of -4.12%.
Is FG a buy, sell or hold?
F&G Annuities & Life has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold FG.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for FG stock price target?
According to ValueRays Forecast Model, FG F&G Annuities & Life will be worth about 36.8 in April 2026. The stock is currently trading at 34.99. This means that the stock has a potential upside of +5.12%.
Issuer Forecast Upside
Wallstreet Target Price 40 14.3%
Analysts Target Price 47 34.3%
ValueRay Target Price 36.8 5.1%